Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
2020 ◽
Vol Volume 13
◽
pp. 2823-2831
2012 ◽
Vol 29
(3)
◽
pp. 313-320
◽
2020 ◽
Vol 36
(10)
◽
pp. 1619-1626
Keyword(s):
2020 ◽
Vol 19
(1)
◽
pp. 69-79
◽